🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

16 recruiting trials

for Tetanus

Clinical Trial of the Adsorbed Acellular Pertussis (Tricomponent) DTaP-Haemophilus Influenzae Type b (Conjugate)-ACYW135 Group Meningococcal (Conjugate) Combined Vaccine NCT07203755Phase 11 site📍 Shangqiu CanSino Biologics Inc. · Tests: Adsorbed Acellular Pertussis (3-Component) Diphtheria-Tetanus-Pertussis-Haemophilus influenzae type b (Conjugate)-Menin… A Phase 4 Study to Evaluate the Effectiveness and Safety of Siltartoxatug Injection for Tetanus Prophylaxis Following Injury NCT07347938n/a1 site📍 Hangzhou Zhuhai Trinomab Pharmaceutical Co., Ltd. · Tests: Siltartoxatug Injection, HTIG/TAT/F(ab')₂ Age-descending Study to Evaluate the Safety and Immunogenicity of the Cholera Conjugate Vaccine in Adults and Children NCT07509047Phase 21 site📍 Nairobi International Vaccine Institute · Tests: OSP:rTTHc CCV 25 ㎍ with Aluminum phosphate, OSP:rTTHc CCV 25 ㎍ without Aluminum phosphate, Euvichol®-Plus, Placebo, CCV… Post Marketing Surveillance Study for MenQuadfi® [Meningococcal (Groups A, C, Y, W) Polysaccharide Tetanus Toxoid Conjugate Vaccine] Administered in Participants Aged 6 Weeks to 55 Years in Republic of Korea NCT07621653n/a9 sites📍 Busan📍 Daegu📍 Goyang Sanofi · Tests: Meningococcal (Groups A, C, Y, W) Polysaccharide Tetanus Toxoid Conjugate Vaccine Immunogenicity and Safety of Diphtheria, Tetanus, Pertussis (DTaP) Vaccine in 3-month-old Infants NCT06344065Phase 31 site📍 Nanning Beijing Zhifei Lvzhu Biopharmaceutical Co., Ltd · Tests: Diphtheria, tetanus and acellular pertussis (component) combined vaccine (adsorbed), Diphtheria, tetanus and acellular … Clinical Trial of the 24-valent Pneumococcal Polysaccharide Conjugate Vaccine (CRM197/Tetanus Toxoid) NCT07600983Phase 1, Phase 22 sites📍 Shangqiu📍 Xuchang CanSino Biologics Inc. · Tests: 24-valent pneumococcal polysaccharide conjugate vaccine (CRM197/tetanus toxoid) (referred to as PCV24) (dose M), PCV24 … Concurrent Versus Sequential Administration of Tdap and RSV Vaccines in Pregnancy NCT07097012Phase 44 sites📍 Vancouver📍 Halifax📍 Ottawa Canadian Immunization Research Network · Tests: Tdap Vaccine Administration, RSV Vaccine, Saline (as a placebo) A Phase I/II Clinical Trial of the Diphtheria, Tetanus, Acellular Component Pertussis and Sabin Inactivated Poliomyelitis Vaccine Adsorbed NCT07891104Phase 1, Phase 23 sites📍 Chongqing📍 Chongqing📍 Chongqing Institute of Medical Biology, Chinese Academy of Medical Sc… · Tests: Diphtheria, Tetanus, Acellular Component Pertussis and Sabin Inactivated Poliomyelitis Vaccine Adsorbed, Diphtheria, Te… Adsorption of Cell-free Diphtheria and Tetanus (Three-component) Combined With Vaccine Phase III Clinical Trial NCT07112144Phase 31 site📍 Wenshan Zhuang and Miao Autonomous Prefecture Changchun BCHT Biotechnology Co. · Tests: DTacP, DTaP, DTacP-IPV/Hib Phase I Clinical Trial of Diphtheria-Tetanus-acellular Pertussis Component Combined Vaccine NCT06184542Phase 13 sites📍 Dazhou📍 Yibin📍 Yibin Institute of Medical Biology, Chinese Academy of Medical Sc… · Tests: DTacP (one-dose booster), DTacP (three-dose primary vaccination), DT (one-dose booster), DTaP (one-dose booster), PENTA… Risk Assessment of Community Spread of Multiple Endemic Infectious Diseases in a One Health Perspective NCT07358910n/a1 site📍 Phnom Penh Institut Pasteur du Cambodge A Registry： Siltartoxatug Injection for Tetanus Prophylaxis Following Injury NCT07107932n/a4 sites📍 Shantou📍 Xiangyun📍 Shaoxing Zhuhai Trinomab Pharmaceutical Co., Ltd. · Tests: Siltartoxatug Injection (Brand name: Sintetol®) A Phase II Clinical Trial of Absorbed Acellular Pertussis (Two-Component) Diphtheria-Tetanus Combined Vaccine (For Adults and Adolescents) NCT07894055Phase 21 site📍 Lishui Changchun BCHT Biotechnology Co. · Tests: Tdap vaccine, Placebo Tetanus Severity Score for Prediction of Mortality in Manifest Tetanus NCT07512167n/a1 site📍 Cairo Ain Shams University · Tests: Tetanus Severity Score (TSS), Philips Score, Dakar Score A Phase I/II Study to Evaluate the Safety and Immunogenicity of GC3111B in Healthy Adults NCT06997627Phase 1, Phase 21 site📍 Seoul GC Biopharma Corp · Tests: GC3111B, Boostrix® Enhancing Maternal Vaccine Knowledge and Uptake: The InTroDuce-Programme Trial NCT06815250NA4 sites📍 Bandar Baru Bangi📍 Cheras📍 Cheras Universiti Putra Malaysia · Tests: Influenza and Tdap Vaccination Educational and Learning Module
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy